Skip to main content
User picture
Phone: +420 585632137
Groups: IMTM, LEM, POSTDOCTORAL FELLOW, STAFF

About me

Scientist and medical professional mainly involved in molecular and translational medicine (disease area paediatric, oncology and medical genetics). Experienced in project management and certification processes, involved as investigator in more than 20 national and international projects, co-founder of spin-off company focused on manufacturing of molecular diagnostics. 
Published more than >65 papers, >7books/chapters, >2 patents,  >290 oral/poster presentations, >1000 SCI citations, H-index 12

Specialties: 
Molecular and translational medicine
Pediatrics, Oncology and Medical Genetics
Circulating tumor cells detection
Molecular profilling of tumors
Prognostic, predictive and diagnostic biomarkers

Responsibility for transcriptomic sequencing, circulating tumor cells detection, PCR based methods, gene expression profiling, SNP and CNV arrays. Biostatistical analyses. Biomedical project coordinator. Quality manager (ISO 15189). Teaching and examination of students, tutor for Bc., MSc. and PhD. students.

Journals

SPURNA, Z., P. CAPKOVA, L. PUNOVA, J. DUCHOSLAVOVÁ, D. ALEKSIJEVIC, J. VENHACOVA, J. SROVNAL, J. STELLMACHOVA, V. CURTISOVA, V. BITNEROVA, K. KOLARIKOVA, M. JANÍKOVÁ, R. KRATOCHVILOVA, R. VRTEL, P. VODICKA, J. ZAPLETALOVÁ
Clinical-genetic analysis of selected genes involved in the development of the human skeleton in 128 Czech patients with suspected congenital skeletal abnormalities. Gene. 2024, 892, 147881, ISSN: 0378-1119, PMID: 37806643,  PDF.
VECERA, L., P. PRASIL, J. SROVNAL, E. BERTA, M. VIDLAŘOVÁ, T. GABRHELIK, P. KOUŘILOVÁ, M. LOVEČEK, P. SKALICKÝ, J. ŠKARDA, Z. KALA, P. MICHALEK, M. HAJDÚCH
Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery. Cancers. 2023, 15(16), 4038, ISSN: 2072-6694, PMID: 37627066,  PDF.
ŘEHULKOVÁ, A., J. CHUDÁČEK, A. PROKOPOVÁ, M. VIDLAŘOVÁ, J. STRÁNSKÁ, J. DRÁBEK, J. POTOČKOVÁ, R. TROJANEC, J. VRBKOVÁ, J. ŠKARDA, T. BOHANES, M. SZKORUPA, B. TOLMACI, J. KLEIN, J. SROVNAL, M. HAJDÚCH
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients. Translational Lung Cancer Research. 2023, 12(5), 1034-1050, ISSN: 2226-4477 , PMID: 37323172,

Books & book chapters

Laboratory Techniques in Cellular and Molecular Medicine, 1.vyd., Olomouc, Palacky University, 2021, 436 s, Dedication: LO1304, ISBN: 978-80-244-6049-9,
Elektrochemické metody, (bio)senzory a čipové platformy, 1.vyd., korigovaný dotisk, Olomouc, Univerzita Palackého v Olonouci, 2021, 2.3, 43-52, ISBN: 978-80-244-3951-8,
Onkogenetika, 1.vyd., Olomouc, Univerzita Palackého v Olomouci, 2018, 109-116, ISBN: 978-80-244-5368-2,

Doctoral mentorship

Stejskal Pavel MSc

Circulating tumor cells detection

Status: Ongoing from 2020.

Master mentorship

Slavík Hanuš M.Sc.

Effect of analgesia on circulating tumor cells levels in colorectal cancer patients

Status: Graduated from 2012 to 2014.

Juřicová Markéta

Mechanism of phenretinide action and effect on miRNA expression in cystic fibrosis models

Status: Graduated from 2019 to 2021.

Rožková Markéta

Molecular characterization of circulating tumor cells in cancer patients

Status: Graduated from 2022 to 2023.

Bachelor mentorship

Svatošová Barbora

Detection of somatic mutations and selected cytogenetic changes in gliomas

Status: Graduated from 2021 to 2023.

Mikuláštíková Michaela

Revision of the variants of unclear significance (VUS) in patients tested for hereditary cancer syndromes in the context of the results of the A-C-G-T project

Status: Graduated from 2021 to 2023.

Resutíková Lucie

Telomerase in solid tumors

Status: Graduated from 2008 to 2008.

Open positions

2 Medical biology
Project: Diagnostics and therapy of rare diseases
Supervisors: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: 2 places in full-time study
Project: New prognostic and predictive factors in solid tumors
Supervisors: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D.
Available: 3
Intended for: Doctoral training
Summary: 3 places in full-time or combined form of study
1 Biomarkers: Identification and validation
Project: New prognostic and predictive factors in solid tumors
Supervisors: Srovnal Josef M.D., Ph.D., Hajdúch Marián M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Summary: Cancer is the second leading cause of death in the western countries. Early diagnosis and targeted therapy improve the therapeutic outcome. With the emergence of new biotechnologies, diagnosis can be made early and precisely, and the knowledge of tumor molecular genetics can identify the most appropriate therapy for a particular patient. The sensitivity of modern molecular methods makes it possible to characterize the tumor properties from sites remote from the primary tumor using patient's blood. The subject of the offered study program is the identification of new prognostic and predictive biomarkers of cancer using liquid biopsies. This is particularly the analysis of circulating tumor cells (CTCs), circulating free tumor DNA (ctDNA) and circulating miRNAs. The aim of the project is to further implement a liquid biopsy concept into the diagnosis and therapy monitoring of solid tumors, especially colorectal, breast, lung and CNS tumors. These include therapy response and resistance monitoring, identifying new therapeutic targets and estimating disease prognosis. The project will provide training in widely-used, transferable techniques, including circulation tumor cells capture system, digital droplet PCR, reverse-transcription qPCR, RNA-seq, single cell analyses, xenografts models and other multi-omics methods. We are looking for candidates with a background in Molecular Biology, Medicine, Cell Biology or a related area, who are enthusiastic about investigating novel approaches in cancer diagnostic that have significant potential for public health.
3 Molecular and Translational Medicine
Project: Diagnosis and treatment of rare diseases
Supervisors: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D.
Available: 2
Intended for: Doctoral training
Project: New prognostic and predictive factors in solid tumors
Supervisors: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D., Koudeláková Vladimíra Ph.D.
Available: 3
Intended for: Doctoral training
Project: Liquid biopsies in experimental and clinical oncology
Supervisors: Srovnal Josef M.D., Ph.D., Koudeláková Vladimíra Ph.D.
Available: 2
Intended for: Doctoral training